Jane Street
SBFM icon

Jane Street’s Sunshine Biopharma SBFM Stock Holding History

Jane Street’s Portfolio SBFM Stock Details SBFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.4K Buy
+749
New +$96K ﹤0.01% 11085
2024
Q3 		– Sell
-7
Closed -$11.6K – 10308
2024
Q2 		$11.6K Buy
+7
New +$66.7K ﹤0.01% 9098
2024
Q1 		– Hold
0
– – – 9007
2022
Q2 		– Hold
0
– -$31K – 10718
2022
Q1 		– Hold
0
– – – 9822

Other funds holding SBFM

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Strive Financial Group
Strive Financial Group Carmel, Indiana $230M AUM
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Jane Street's SBFM Position: Q2 2026 in Review

Jane Street opened a new position in Sunshine Biopharma (SBFM) in Q2 2026: 749 shares worth $31.4K. The stake represents ﹤0.01% of the portfolio and ranks #11085 among its holdings. This is a return to the name: Jane Street previously reported a position in SBFM as recently as Q2 2024.

Jane Street first reported a position in SBFM in Q2 2024 and has held it in 2 quarters since. 3 funds tracked by Wall St. Rank hold SBFM as of Q2 2026.

  • Jane Street held 749 shares of Sunshine Biopharma worth $31.4K as of Q2 2026.
  • Sunshine Biopharma was a new Jane Street position in Q2 2026.
  • Sunshine Biopharma made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11085 holding.
  • Jane Street first reported a position in Sunshine Biopharma in Q2 2024 and has held it in 2 quarters since.
  • 3 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.